(Circulation. 2000;101:231.)
© 2000 American Heart Association, Inc.
Brief Rapid Communications |
Enteroviral Capsid Protein VP1 Is Present in Myocardial Tissues From Some Patients With Myocarditis or Dilated Cardiomyopathy
From the Molecular Pathology Section, Division of Biomedical Sciences (Y.L., L.C.A., H.Z.) and Infectious Disease and Medical Microbiology (H.Z.), Imperial College of Science, Technology, and Medicine, London, UK; Laboratoire de Bactériologie-Virologie (Y.L., T.B., B.P.) and Laboratoire d’Anatomo-Pathologie (J.-F.M.), Faculté de Médecine Jacques Lisfranc, Saint-Etienne, and Laboratoire de Virologie, Faculté de Médecine, Lille (L.A.), France; and Key Laboratory of Viral Heart Disease, Ministry of Public Health, Zhongshan Hospital, Shanghai Medical University, PRC (Y.L., T.P., Y.Y.).
Correspondence to Dr Hongyi Zhang, Molecular Pathology, DBS, SAF Building, ICSTM, Exhibition Road, London SW7 2AZ, UK. E-mail h.zhang{at}ic.ac.uk
Background—There are still discrepancies in the association of enterovirus and myocardial disease, partially due to lack of data on the detection of virus antigens in tissues. It is desirable to localize enteroviral antigens so as to establish a link between the two and to study mechanisms of virus persistence.
Methods and Results—Nineteen fixed explanted or postmortem
myocardial samples were obtained from patients with myocarditis or
dilated cardiomyopathy (DCM). Control samples were
collected from 11 subjects who had died accidentally or of
noncardiovascular disease. Viral antigen was detected
by an improved immunohistochemical technique using an enterovirus
group–specific antibody to viral capsid protein VP1. Nine of 11
myocarditis cases (81.8%) and 6 of 8 DCM cases (75%) were positive.
Signals were localized in the cytoplasm of myocytes. Intense
immunostaining was observed in acute myocarditis,
whereas VP1 was detected in scattered myocytes in chronic myocarditis
or DCM. Enteroviral RNA was detected in 6 of 11 myocarditis samples
(54.5%) and 3 of 8 DCM samples (37.5%) by the reverse
transcription–nested polymerase chain reaction, correlating with
antigen detection (
=0.6±0.21). Neither viral antigen nor RNA was
detected in any controls.
Conclusions—Our findings demonstrate a direct link between enterovirus infection and some myocarditis or DCM cases. The pattern of VP1 detection may correlate with disease stage and severity. The data suggest that viral protein synthesis may be involved in persistent enterovirus infection in the pathogenesis of DCM.
Key Words: cardiomyopathy • myocarditis • viruses • antigens • immunohistochemistry
This article has been cited by other articles:
 |
|
 |
|
  L. Andreoletti Reply. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 82 - 83. [Full Text] [PDF]
|
|
|
|
|
|
L. Andreoletti, L. Venteo, F. Douche-Aourik, F. Canas, G. L. de la Grandmaison, J. Jacques, H. Moret, N. Jovenin, J.-F. Mosnier, M. Matta, et al. Active Coxsackieviral B Infection Is Associated With Disruption of Dystrophin in Endomyocardial Tissue of Patients Who Died Suddenly of Acute Myocardial Infarction J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2207 - 2214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Xiong, T. Yajima, B.-K. Lim, A. Stenbit, A. Dublin, N. D. Dalton, D. Summers-Torres, J. D. Molkentin, H. Duplain, R. Wessely, et al. Inducible Cardiac-Restricted Expression of Enteroviral Protease 2A Is Sufficient to Induce Dilated Cardiomyopathy Circulation, January 2, 2007; 115(1): 94 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-K. Lim, J.-H. Choi, J.-H. Nam, C.-O. Gil, J.-O. Shin, S.-H. Yun, D.-K. Kim, and E.-S. Jeon Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis Cardiovasc Res, August 1, 2006; 71(3): 517 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J K S Chia The role of enterovirus in chronic fatigue syndrome J. Clin. Pathol., November 1, 2005; 58(11): 1126 - 1132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-S. Kim, S. Tracy, W. Tapprich, J. Bailey, C.-K. Lee, K. Kim, W. H. Barry, and N. M. Chapman 5'-Terminal Deletions Occur in Coxsackievirus B3 during Replication in Murine Hearts and Cardiac Myocyte Cultures and Correlate with Encapsidation of Negative-Strand Viral RNA J. Virol., June 1, 2005; 79(11): 7024 - 7041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nishii, T. Inomata, H. Takehana, I. Takeuchi, H. Nakano, T. Koitabashi, J.-i. Nakahata, N. Aoyama, and T. Izumi Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1292 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W Mason Myocarditis and dilated cardiomyopathy: An inflammatory link Cardiovasc Res, October 15, 2003; 60(1): 5 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Calabrese and G. Thiene Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects Cardiovasc Res, October 15, 2003; 60(1): 11 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Baboonian and W. McKenna Eradication of viral myocarditis: Is there hope? J. Am. Coll. Cardiol., August 6, 2003; 42(3): 473 - 476. [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Zhang, B. Yanagawa, P. Cheung, H. Luo, J. Yuan, D. Chau, A. Wang, L. Bohunek, J. E. Wilson, B. M. McManus, et al. Nip21 Gene Expression Reduces Coxsackievirus B3 Replication by Promoting Apoptotic Cell Death via a Mitochondria-Dependent Pathway Circ. Res., June 28, 2002; 90(12): 1251 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Muir Enterovirus infection of the heart--a causal or contributory factor in chronic rheumatic heart disease? Eur. Heart J., April 1, 2002; 23(7): 517 - 520. [Full Text] [PDF]
|
|
|
|
|
|
Y Li, Z Pan, Y Ji, T Peng, L.C Archard, and H Zhang Enterovirus replication in valvular tissue from patients with chronic rheumatic heart disease Eur. Heart J., April 1, 2002; 23(7): 567 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-K. Lim, S.-C. Choe, J.-O. Shin, S.-H. Ho, J.-M. Kim, S.-S. Yu, S. Kim, and E.-S. Jeon Local Expression of Interleukin-1 Receptor Antagonist by Plasmid DNA Improves Mortality and Decreases Myocardial Inflammation in Experimental Coxsackieviral Myocarditis Circulation, March 19, 2002; 105(11): 1278 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Badorff, A M Zeiher, and S H Hohnloser Torsade de pointes tachycardia as a rare manifestation of acute enteroviral myocarditis Heart, November 1, 2001; 86(5): 489 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Henke, R. Zell, G. Ehrlich, and A. Stelzner Expression of Immunoregulatory Cytokines by Recombinant Coxsackievirus B3 Variants Confers Protection against Virus-Caused Myocarditis J. Virol., September 1, 2001; 75(17): 8187 - 8194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.-W. Seong, S.-C. Choe, and E.-S. Jeon Fulminant Coxsackieviral Myocarditis N. Engl. J. Med., August 2, 2001; 345(5): 379 - 379. [Full Text] [PDF]
|
|
|
|
|
|
T. Peng, T. Sadusky, Y. Li, G. R. Coulton, H. Zhang, and L. C. Archard Altered expression of Bag-1 in Coxsackievirus B3 infected mouse heart Cardiovasc Res, April 1, 2001; 50(1): 46 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Feldman and D. McNamara Myocarditis N. Engl. J. Med., November 9, 2000; 343(19): 1388 - 1398. [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Reetoo, S. A. Osman, S. J. Illavia, C. L. Cameron-Wilson, J. E. Banatvala, and P. Muir Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease J. Gen. Virol., November 1, 2000; 81(11): 2755 - 2762. [Abstract] [Full Text]
|
|
|
|
|
|
C. Badorff, B. Fichtlscherer, R. E. Rhoads, A. M. Zeiher, A. Muelsch, S. Dimmeler, and K. U. Knowlton Nitric Oxide Inhibits Dystrophin Proteolysis by Coxsackieviral Protease 2A Through S-Nitrosylation : A Protective Mechanism Against Enteroviral Cardiomyopathy Circulation, October 31, 2000; 102(18): 2276 - 2281. [Abstract] [Full Text] [PDF]
|
|